⌘K

Login Start Free

Home/Filings/4/0001562180-24-006671

4//SEC Filing

Hassan Fred 4

Accession 0001562180-24-006671

CIK 0001314102other

View on SEC.gov Company Profile

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:02 PM ET

Size

5.8 KB

Accession

0001562180-24-006671

Insider Transaction Report

Form 4

Period: 2024-09-03

EyePoint Pharmaceuticals, Inc.EYPT

Director

Transactions

Award
Stock Options (Right to buy)
2024-09-03+60,000→ 60,000 total
Exercise: $8.16Exp: 2034-09-03→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]The option becomes exercisable in three ratable annual installments beginning on September 3, 2025.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1

filerCIK 0001110744

Filing Metadata

Form type: 4
Filed: Sep 4, 8:00 PM ET
Accepted: Sep 5, 4:02 PM ET
Size: 5.8 KB

View on SEC.gov